Comparcini Dania, Tomietto Marco, Pastore Francesco, Nichol Bethany, Miniscalco Daniela, Flacco Maria Elena, Stefanizzi Pasquale, Tafuri Silvio, Cicolini Giancarlo, Simonetti Valentina
Interdisciplinary Department of Medicine, "Aldo Moro", University of Bari, 70121 Bari, Italy.
Department of Nursing, Midwifery and Health, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne NE1 8ST, UK.
Vaccines (Basel). 2024 Jul 14;12(7):772. doi: 10.3390/vaccines12070772.
Vaccination among pregnant and breastfeeding women is critical for protecting this vulnerable population and their children. COVID-19 vaccination is recommended both during pregnancy and breastfeeding; however, we still do not fully understand the determinants that influence hesitancy towards COVID-19 vaccination. This study aimed to identify the determinants of vaccine hesitancy in pregnant and breastfeeding, puerperium women. A multicenter, cross-sectional study, involving 435 pregnant and breastfeeding women, was conducted. Vaccination hesitancy was evaluated by administering the Vaccination Attitudes (VAX) Scale and the Zung Anxiety Self-Assessment Scale (SAS) was adopted to measure anxiety levels. Overall, 14% of the participants reported that they did not receive the COVID-19 vaccine, and 78.3% received their first dose during pregnancy or while breastfeeding. The descriptive statistics for the VAX scale showed a total mean score of 3.35 (±1.6), and 75% of participants reported an anxiety index equal to or lower than the threshold. Vaccine hesitancy increased as "adverse events after vaccination" increased ( < 0.01), while SAS levels positively correlated with the participants' mean age ( < 0.05). Investigating the factors influencing vaccine hesitancy enables the development of targeted health policies and SARS-CoV-2 vaccination programs.
孕妇和哺乳期妇女接种疫苗对于保护这一弱势群体及其子女至关重要。建议在孕期和哺乳期接种新冠病毒疫苗;然而,我们仍未完全了解影响新冠病毒疫苗接种犹豫的决定因素。本研究旨在确定怀孕、哺乳及产褥期妇女疫苗犹豫的决定因素。开展了一项多中心横断面研究,纳入435名怀孕和哺乳期妇女。通过使用疫苗接种态度(VAX)量表评估疫苗接种犹豫情况,并采用zung焦虑自评量表(SAS)测量焦虑水平。总体而言,14%的参与者表示未接种新冠病毒疫苗,78.3%在孕期或哺乳期接种了第一剂疫苗。VAX量表的描述性统计显示,总平均分为3.35(±1.6),75%的参与者报告焦虑指数等于或低于阈值。随着“接种后不良事件”增加,疫苗犹豫情况增加(<0.01),而SAS水平与参与者平均年龄呈正相关(<0.05)。调查影响疫苗犹豫的因素有助于制定有针对性的卫生政策和新冠病毒疫苗接种计划。